Opticoustic sensor
US-9326712-B1 · May 3, 2016 · US
US10328202B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10328202-B2 |
| Application number | US-201615006018-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 25, 2016 |
| Priority date | Feb 4, 2015 |
| Publication date | Jun 25, 2019 |
| Grant date | Jun 25, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and systems are provided for determining fluid administration. The system may determine fluid administration based on the fluid responsiveness and regional oxygen saturation of a subject. The system may receive the fluid responsiveness and regional oxygen saturation from external sources or may determine one or both based on received physiological signals. In some embodiments, the system may determine whether to administer fluid based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the amount of fluid to administer based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the effectiveness of fluid administration. In some embodiments, the system may provide an indication of the determined fluid administration so that a care-giver can implement the appropriate fluid administration. In some embodiments, the system may control the fluid administration based on its determination.
Opening claim text (preview).
What is claimed: 1. A physiological monitoring system comprising: a pulse oximetry sensor configured to: detect at least one first wavelength of light from a first tissue of a subject; and generate a photoplethysmograph (PPG) signal based on the detected at least one first wavelength of light; a regional oxygen saturation sensor configured to detect at least one second wavelength of light from a second tissue of the subject and determine a value indicative of regional oxygen saturation in the second tissue; and a processor coupled to the pulse oximetry sensor and the regional oxygen saturation sensor, wherein the processor is configured to: receive the PPG signal; determine a value indicative of fluid responsiveness of the subject based on a change in the PPG signal over time; receive the value indicative of regional oxygen saturation in the second tissue; and determine whether to administer fluid to the subject based on the value indicative of regional oxygen saturation and the value indicative of fluid responsiveness. 2. The system of claim 1 , wherein the value indicative of fluid responsiveness is determined based on respiratory variations identified in the PPG signal. 3. The system of claim 1 , wherein the value indicative of fluid responsiveness is determined based on amplitude variations in the PPG signal. 4. The system of claim 1 , wherein the value indicative of fluid responsiveness is determined based on variations of a percent modulation of the PPG signal. 5. The system of claim 1 , wherein the value indicative of regional oxygen saturation is indicative of oxygen saturation in at least one of the subject's brain, kidney, and abdomen. 6. The system of claim 1 further comprising a fluid administration mechanism coupled to the processor configured to administer fluid to the subject based on the processor's determination of whether to administer fluid. 7. The system of claim 6 , wherein the fluid administration mechanism comprises a syringe and an automated pump mechanism coupled to the syringe that actuates the syringe to administer fluid to the subject based on the processor's determination of whether to administer fluid. 8. The system of claim 1 , wherein the processor is configured to determine whether to administer fluid to the subject by: comparing the value indicative of fluid responsiveness to a fluid responsiveness threshold; comparing the value indicative of regional oxygen saturation to a regional oxygen saturation threshold; and determining whether to administer fluid to the subject based on both comparisons. 9. The system of claim 8 , wherein the regional oxygen saturation threshold is indicative of adequate perfusion of a region associated with the value indicative of regional oxygen saturation. 10. The system of claim 1 , wherein the processor is configured to determine the amount of fluid to administer to the subject based on the value indicative of regional oxygen saturation and the value indicative of fluid responsiveness. 11. The system of claim 1 , comprising a display configured to display the value indicative of fluid responsiveness and an indication of fluid administration upon a determination to administer fluid to the subject. 12. A physiological monitoring system comprising: a monitor configured to receive a first plurality of physiological signals generated by a pulse oximetry sensor coupled to the physiological monitoring system and a second plurality of physiological signals generated by a regional oxygen saturation sensor coupled to the physiological monitoring system, wherein the first plurality of physiological signals are indicative of light detected from a first tissue of a subject and the second plurality of physiological signals are indicative of light detected from a second tissue of the subject, the monitor comprising a processor configured to: calculate regional oxygen saturation in the second tissue of the subject based on the second plurality of physiological signals, wherein the second plurality of physiological signals comprise signals from a first detector and a second detector spaced apart from the first detector, and wherein the regional oxygen saturation is calculated based on a differential absorption of light in the second tissue as detected at the first detector relative to the second detector; calculate a parameter indicative of fluid responsiveness based on the first plurality of physiological signals; and provide an indication to administer fluid to the subject based on the regional oxygen saturation and the parameter indicative of fluid responsiveness. 13. The system of claim 12 , wherein the processor is configured to calculate the parameter indicative of fluid responsiveness based on respiratory-induced amplitude variations identified in one of the first plurality of physiological signals. 14. The system of claim 12 , wherein the processor is configured to calculate the parameter indicative of fluid responsiveness based on variations of a percent modulation of the first plurality of physiological signals. 15. The system of claim 12 , wherein the processor is configured to determine whether to administer fluid to the subject based on the regional oxygen saturation and the parameter indicative of fluid responsiveness. 16. The system of claim 12 , wherein the processor is configured to determine an amount of fluid to be administered to the subject based on the regional oxygen saturation and the parameter indicative of fluid responsiveness. 17. The system of claim 12 , wherein the processor is configured to determine the effectiveness of fluid administration based on a change in at least one of the regional oxygen saturation and the parameter indicative of fluid responsiveness. 18. The system of claim 17 , wherein the processor is configured to control the fluid administration of the subject based on the effectiveness of the fluid administration. 19. The system of claim 12 , wherein the second tissue for which regional oxygen saturation is calculated is at least one of the subject's brain, kidney, and abdomen. 20. The system of claim 12 , wherein the processor is configured to control the fluid administration of the subject based on the regional oxygen saturation and the parameter indicative of fluid responsiveness.
Monitoring or testing the effects of treatment, e.g. of medication · CPC title
using feedback of body parameters, e.g. blood-sugar, pressure (measurement of body parameters A61B5/00) · CPC title
using photoplethysmograph signals, e.g. generated by infrared radiation (A61B5/14552 takes precedence) · CPC title
Measuring devices for evaluating the respiratory organs · CPC title
Hydration status, fluid retention of the body · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.